NCT03573622View on ClinicalTrials.gov

A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

May 31, 2018

Primary Completion Date

August 21, 2018

Study Completion Date

October 12, 2018

Conditions
Healthy
Interventions
DRUG

Anpl-one SR Tab. 300mg

Anpl-one SR Tab. 300mg tablets followed by Sarpodipil SR Tab. 300mg tablets

DRUG

Sarpodipil SR Tab. 300mg

Sarpodipil SR Tab. 300mg tablets followed by Anpl-one SR Tab. 300mg tablets

Trial Locations (1)

06170

Daewoong pharmatceutical, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY